Columbus Circle Investors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Columbus Circle Investors's EW Position: Q4 2020 in Review
Columbus Circle Investors sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 27,300 shares — an estimated $2.18M sold.
Columbus Circle Investors first reported a position in EW in Q3 2014 and held it in 20 quarters. The position peaked at $242M in Q3 2016. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.
- Columbus Circle Investors reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
- Columbus Circle Investors sold 27,300 Edwards Lifesciences shares in Q4 2020, an estimated $2.18M.
- Columbus Circle Investors first reported a position in Edwards Lifesciences in Q3 2014 and held it in 20 quarters.
- Columbus Circle Investors's Edwards Lifesciences position peaked at $242M in Q3 2016.
- 1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.
Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.